Eyes on Chi­na stocks: Lon­car loads new ETF with his picks for most promis­ing biotechs on HKEX and Nas­daq

An in­vestor group based in the Mid­west is tap­ping the boom­ing biotech scene in Chi­na to launch a new in­vest­ment ve­hi­cle for traders in­ter­est­ed in promis­ing Chi­nese ven­tures.

Lon­car In­vest­ments, found­ed by in­de­pen­dent biotech in­vestor Brad Lon­car, se­lect­ed 28 com­pa­nies — some list­ed on the Hong Kong Stock Ex­change and the rest on the Nas­daq — to wrap up in­to an ex­change-trad­ed fund: Lon­car Chi­na Bio­Phar­ma ETF. The tick­er is Nas­daq: $CHNA.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.


Alexandria Real Estate Equities

San Diego, CA, USA